Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback